Concepedia

Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction

Ola Kleveland, Thor Ueland, Gabor Kunszt, Marte Bratlie, Arne Yndestad, Kaspar Broch, Espen Holte, Liv Ryan, Brage H. Amundsen, Bjørn Bendz,

International Journal of Cardiology · 2018 · 35 citations · 17 references

DOIFull text

Open access

Concepts

References

17

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Paul M. Ridker, Tom Thurén, Jean MacFadyen et al. · New England Journal of Medicine · 2017 · 9.1K citations · Full text

, , +17

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Marco Roffi, Jean‐Philippe Collet, Christian Mueller et al. · European Heart Journal · 2015 · 8.3K citations · Full text

, , +16

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

European Heart Journal · 2011 · 3.1K citations · Full text

, , +17

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Josef S Smolen, André Beaulieu, Andrea Rubbert‐Roth et al. · The Lancet · 2008 · 1.4K citations

, , +16

Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytes

José V. Castell, Marı́a José Gómez-Lechón, Martina David et al. · FEBS Letters · 1989 · 901 citations

, , +16